Ningxia Zhongke Biotechnology Co., Ltd. (600165.SS) SHH

Currency In CNY

AD

Valuation

Market Cap6.7B
Enterprise Value6.25B
P/E Ratio-31.26
PEG Ratio-0.23
Price/Sales Ratio10.31
Price/Book Ratio4.82
Enterprise/Revenue9.95
Enterprise/EBITDA340.1

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.1
Operating Margin-0.17
AD

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.06

Income Statement

Revenue444.48M
Revenue/Share0.31
Gross Profit-88.7M
EBITDA-2.73M
Net Income-90.38M
Diluted EPS-0.06

Balance Sheet

Total Cash189.97M
Total Cash/Share0.12
Total Debt11.21M
Total Debt/Equity0.01
Current Ratio2.33
Book Value Per Share0.74

Price History

52-Week Change-17.48
52-Week High4.44
52-Week Low2.15
Moving Average 50 Days2.74
Moving Average 200 Days3.32

Statistics

Average Volume11.15M
Shares Outstanding1.62B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.12
Last Split Factor5:2
Last Split DateOctober 12, 2015
AD